Abstract
Ethylene glycol is an osmotically active organic alcohol responsible for nearly 6000 intentional and accidental ingestions annually. It may be found in many industrial and household products including antifreeze and de-icing solutions, brake and hydraulic fluids, and window cleaners. Ethylene glycol, itself, has little toxicity but its metabolites can cause serious morbidity and mortality.
Initial effects from ethylene glycol ingestion may resemble intoxication from ethanol, and patients may exhibit dysarthria, ataxia, confusion, stupor and even coma. The parent compound is metabolized in the liver via alcohol dehydrogenase and aldehyde dehydrogenase resulting in the production of glycolic acid. This metabolite is chiefly responsible for the anion-gap acidosis that develops, and can exert significant cardiopulmonary toxicity. A small amount of glycolic acid is further metabolized into oxalate, which leads to calcium oxalate deposition in renal tubules and subsequent renal injury.
The diagnosis of ethylene glycol poisoning can be challenging, as patients may not be forthcoming, or may present too altered to provide a history of ingestion. Ethylene glycol levels may not be readily available at the treating institution. Either a high index of suspicion, or the presence of an unexplained osmolal gap or anion gap acidosis, should prompt empiric treatment to maximize favorable outcomes. Enzymatic inhibition of alcohol dehydrogenase through the use of fomepizole or ethanol is the cornerstone of successful management. In later presentations where a significant anion gap acidosis has developed, or when renal injury is apparent, hemodialysis must be considered.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
McQuade DJ, Dargan PI, Wood DM. Challenges in the diagnosis of ethylene glycol poisoning. Ann Clin Biochem. 2013;51(2):167–78.
Buchanan JA, Alhelail M, Cetaruk EW, Schaeffer TH, Palmer RB, Kulig K, et al. Massive ethylene glycol ingestion treated with fomepizole alone—a viable therapeutic option. J Med Toxicol. 2010;6(2):131–4.
Hantson P. Indicators of poor prognosis in toxic alcohols poisoning. Toxicol Lett. 2011;205:S13–4.
Brent J. Fomepizole for ethylene glycol and methanol poisoning. N Engl J Med. 2009;360(21):2216–23.
Druteika DP, Zed PJ, Ensom MH. Role of fomepizole in the management of ethylene glycol toxicity. Pharmacotherapy. 2002;22(3):365–72.
Barceloux DG, Krenzelok EP, Olson K, Watson W. American academy of clinical toxicology practice guidelines on the treatment of ethylene glycol poisoning. Clin Toxicol. 1999;37(5):537–60.
Porter WH, Rutter PW, Bush BA, Pappas AA, Dunnington JE. Ethylene glycol toxicity: the role of serum glycolic acid in hemodialysis. J Toxicol Clin Toxicol. 2001;39(6):607–15.
Mycyk MB, Wills B, Mazor S, Deslauriers C, Metz J. Fomepizole use is often suboptimal in cases of toxic alcohol poisoning. Ann Emerg Med. 2004;44(4):S89.
Khajuria A, Krahn J. Osmolality revisited: deriving and validating the best formula for calculated osmolality. Clin Biochem. 2005;38(6):514–9.
Catchings T, Beamer W, Lundy L, et al. Adult respiratory distress syndrome secondary to ethylene glycol ingestion. Ann Emerg Med. 1985;14:594–6.
Krasowski MD, Wilcoxon RM, Miron J. A retrospective analysis of glycol and toxic alcohol ingestion: utility of anion and osmolal gaps. BMC Clin Pathol. 2012;12(1):2–10.
Brent J, McMartin K, Phillips S, Burkhart KK, Donovan JW, Wells M, Kulig K, Methylpyrazole for Toxic Alcohols Study Group. Fomepizole for the treatment of ethylene glycol poisoning. N Engl J Med. 1999;340(11):832–8.
McStay CM, Gordon PE. Images in clinical medicine: urine fluorescence in ethylene glycol poisoning. N Engl J Med. 2007;356(6):611.
Hauvik LE, Varghese M, Nielsen EW. Lactate gap: a diagnostic support in severe metabolic acidosis of unknown origin. Case Rep Med. 2018;2018:5238240.
Sagar AS, Kimenez CA, McKelvy BJ. Lactate gap as a tool in identifying ethylene glycol poisoning. BMJ Case Rep. 2018;2018:bcr-2018-224243. https://doi.org/10.1136/bcr-2018-224243.
Velez LI, Shepard G, Lee YC, Keyes DC. Ethylene glycol ingestions treated only with fomepizole. J Med Toxicol. 2007;3(3):125–8.
Hall TL. Fomepizole in the treatment of ethylene glycol poisoning. CJEM. 2002;4(3):199–204.
Peterson CD, Collins AJ, Himes JM, Bullock ML, Keane WF. Ethylene glycol poisoning: pharmacokinetics during therapy with ethanol and hemodialysis. N Engl J Med. 1981;304(1):21–3.
Howland MS. Antidotes in depth: fomepizole. In: Nelson LS, Lewin NA, Howland MA, Hoffman RS, Goldfrank LR, Flomenbaum NE, editors. Goldfrank’s toxicologic emergencies. New York: McGraw-Hill; 2010.
Kostic MA, Dart RC. Rethinking the toxic methanol level. J Toxicol Clin Toxicol. 2003;41:793–800.
Rehman H. Fomepizole for toxic alcohol poisoning. N Engl J Med. 2009;361(12):1213–4.
Ting SM, Ching I, Nair H, Langman G, Suresh V, Temple RM. Early and late presentations of ethylene glycol poisoning. Am J Kidney Dis. 2009;53(6):1091–7.
Wedge MK, Mataajan S, Johanson C, Patel R, Kanji S. The safety of ethanol infusions for the treatment of methanol or ethylene glycol intoxication: an observational study. CJEM. 2012;14(5):283–9.
Butler GK. When is it appropriate to treat ethylene glycol intoxication with fomepizole alone without hemodialysis? Semin Dial. 2011;24(4):441–2.
Battistella M. Fomepizole as an antidote for ethylene glycol poisoning. Ann Pharmacother. 2002;36(6):1085–9.
Megarban B, Borron SW, Baud FJ. Current recommendations for treatment of severe toxic alcohol poisonings. Intensive Care Med. 2005;31(2):189–95.
Moreau CL, Kerns W II, Tomaszewski CA, McMartin KE, Rose SR, Ford MD, et al. Glycolate kinetics and hemodialysis clearance in ethylene glycol poisoning. Methylpyrazole for Toxic Alcohols Study Group. J Toxicol Clin Toxicol. 1998;36(7):659–66.
Buller GK, Moskowit CB, Eckardt K. The role of hemodialysis and fomepizole in ethylene glycol intoxication. J Nephrol Therapeutic. 2012;S10:4.
Beatty L, Green R, Magee K, Zed P. A systematic review of ethanol and fomepizole use in toxic alcohol ingestions. Emerg Med Int. 2013;2013:638057.
Watson WA. Ethylene glycol toxicity: closing in on rational, evidence-based treatment. Ann Emerg Med. 2000;36:139–41.
Levine M, et al. Ethylene glycol elimination kinetics and outcomes in patients managed without hemodialysis. Ann Emerg Med. 2012;59(6):527.
Borron SW, Megarbane B, Baud FJ. Fomepizole in treatment of uncomplicated ethylene glycol poisoning. Lancet. 1999;354:831.
Caravati EM, Heileson HL, Jones M. Treatment of severe pediatric ethylene glycol intoxication without hemodialysis. J Toxicol Clin Toxicol. 2004;42(3):255–9.
Barceloux DG, Bond GR, Krenzelok EP, Cooper H, Vale JA. American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. J Toxicol Clin Toxicol. 2002;40(4):415–46.
Lheureux P, Penaloza A, Gris M. Pyridoxine in clinical toxicology: a review. Eur J Emerg Med. 2005;12:78–85.
Jammalamadaka D, Raissi S. Ethylene glycol, methanol, and isopropyl alcohol intoxication. Am J Med Sci. 2010;339(9):276–81.
Bennett IL, Cary FH, Mitchell GL, Cooper MN. Acute methyl alcohol poisoning: a review based on experiences in an outbreak of 323 cases. Medicine. 1953;32(4):431–63.
Sharma R, Marasini S, Sharma A, Shrestha J, Nepal B. Methanol poisoning: ocular and neurological manifestations. Optom Vis Sci. 2012;89(2):178–82.
Zakharov S, Pelclova D, Diblik P, Urban P, Kuthan P, Nurieva O, et al. Lon-term visual damage after acute methanol poisonings: longitudinal cross-sectional study in 50 patients. Clin Toxicol. 2015;53(9):884–92.
Noker P, Ells J, Tephly T. Methanol toxicity: treatment with folic acid and 5-formyl tetrahydrofolic acid. Alcohol Clin Exp Res. 2008;4(4):378–83.
Roberts D, Yates C, Megarbane B, Winchester J, McClaren R, Gosselin S, et al. Recommendations for the role of extracorporeal treatments in the management of acute methanol poisoning: a systematic review and consensus statement. Extracorporeal Treatments in Poisoning Workgroup. Crit Care Med. 2015;43(2):461–72.
Slaughter R, Mason R, Beasley D, Vale J, Schep L. Isopropanol poisoning. Clin Toxicol. 2014;52(5):470–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Brent, C.M., Shaffer, R.W. (2020). Diagnosis and Management of Ethylene Glycol Ingestion. In: Hyzy, R.C., McSparron, J. (eds) Evidence-Based Critical Care. Springer, Cham. https://doi.org/10.1007/978-3-030-26710-0_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-26710-0_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-26709-4
Online ISBN: 978-3-030-26710-0
eBook Packages: MedicineMedicine (R0)